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The Effect of Interspecies Signaling on Stenotrophomonas maltophilia Growth 
Zachary Dickinson 
May 2016 
Cystic fibrosis (CF) is a genetic disorder that effects over 70,000 people worldwide, and 
is particularly prevalent in those of Caucasian descent. CF increases susceptibility to chronic 
infections of the lungs and GI tract, often leading to decreased quality of life and early death to 
afflicted individuals. No cure is available, and so treatment is limited to treating the frequent 
infections that afflict CF patients. Several species of bacteria are commonly implicated in these 
infections, including Stenotrophomonas maltophilia. Infections of this species is of particular 
interest as it has been shown to be highly antibiotic resistant. This is a concern when it is part of 
coinfections with other, more virulent species, such as Pseudomonas aeruginosa. It has been 
shown that these two species are much more difficult to treat when they are present together than 
either one is alone.  
There is thought to be a molecular signaling mechanism through which these two species 
are able to communicate and increase each other’s resilience, although the exact identity of that 
mechanism is unknown. This study began by identifying (based on bioinformatics) six likely 
candidates for quorum sensing receptor proteins. Through insertional interruption, five of these 
genes were made nonfunctional and these constructs were tested to identify a growth phenotype 
of S. maltophilia in the presence and absence of P. aeruginosa. Results of this study may suggest 
that none of the selected gene products play a role in communication between these two species, 
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Introduction and Background: 
Stenotrophomonas maltophilia is a species of gram-negative, nonfermentive bacteria that 
is not generally pathogenic to healthy humans(2). S. maltophilia is able to colonize a large variety 
of environmental habitats including soils, fluid media, and the surfaces of plants (3). It general, S. 
maltophilia is unable to infect human hosts because it is unable to easily bypass the basic 
immune defenses(3). In spite of this, S. maltophilia has been gaining increased attention as an 
emerging pathogen in the past two decades for a number of reasons, especially in hospital 
settings(2,6, 8, 10). S. maltophilia has been shown to be highly resistant to a suite of antibiotics, 
including quinones, β-lactams (carbapenems, penicillins, cephalosporins) and 
aminoglycosides(3).  Additionally, S. maltophilia is able to colonize plastic surfaces (as a result of 
adaptations that include a positively charged surface and fimbrial adhesions).  As a result, it is 
now commonly found on a variety of common medical equipment, including catheters, 
endotracheal tubes, and other indwelling-lines that aid in the bacteria’s transmission into its 
host(3). Once entry into the a host has been established, S. maltophilia infection primarily results 
in pneumonia, but bloodstream infections (septicemia), infection on the skin and soft tissues, 
urinary tract infections, intraabdominal infections, and even ocular infections can also occur(8).  
S. maltophilia infections occur most frequently in immunocompromised and chronically 
ill patients(2) and are of particular concern for patients with cystic fibrosis (CF). Cystic fibrosis is 
the most prevalent genetic disorder among people of European descent(9). As a genetic disorder, 
cystic fibrosis is a result of mutations in the gene encoding the Cystic Fibrosis Transmembrane 
Conductance Regulator (CFTR)(1). Most often (in about 71% of patients with CF), the 
dysfunction is caused by a deletion of the phenylalanine codon 508 in the CTFR gene (9). CTFR 
functions as a chloride transporter and is a critical component of maintaining proper 
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chemiosmotic balances across cellular membranes(9). As such, this protein is critical in the 
production of sweat, digestive fluids, and mucus. Individuals born with a faulty copy of CTFR 
from each parent are unable to produce normal secretions.  
The inability to maintain chemiosmotic balance is especially problematic for the 
secretions in the lungs. In healthy individuals, the lungs secrete a thin lubricant. Any foreign 
material, such as dust or potential pathogens, is caught in this secretions and the cilia lining the 
epithelia of the lungs can easily clear this secretion, bringing it to the back of the throat where it 
can be coughed up or swallowed. Since CF patients do not maintain the proper balance of 
extracellular ions, the volume of pericellular fluid is drastically reduced and mucus clearance is 
severely hindered(1). This creates a warm, humid environment that is created is ideal for 
colonization by bacteria, setting up CF patients for chronic infections in the lungs(1). 
Historically, CF was a deadly condition that resulted in severely shortened life 
expectancies of afflicted individuals(7). This was due primarily to chronic infections of the 
respiratory tract that would eventually cause a severe decline in lung function and lung failure. 
This process begins as an inflammatory response to the growing populations of bacteria in the 
lungs. The body attempts to mount a defense, leading to a chronic neutrophil-dominated 
infection and persistent inflammatory response resulting in tissue necrosis and tissue scarring 
that prevents gas exchange in respiration(7). This decline continues until the patient receives a 
transplant of a healthy lung or lung function degrades sufficiently enough as to cause death. In 
recent decades, thanks to the advent of advancing aggressive antibiotic therapies, individuals 
with CF are living well beyond their forties, whereas before they often did not survive childhood. 
Even with antimicrobial therapies, the main problem for CF patients is the chronic inflammatory 
state that results from persistent infections. With preemptive and aggressive antibiotic treatment, 
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these chronic infections take longer to develop, and the resultant tissue necrosis occurs much 
later in life.  As a result, quality of life for CF patients is greatly improved and life expectancy 
has increased by decades(7). 
As CF patients are increasingly able to live well into adulthood, the complications that 
arise from persistent antibiotic use are becoming clearer. As CF patients age, they begin to 
acquire bacteria not so easily cleared by many front-line antibiotics. These bacteria include 
Stenotrophomonas maltophilia, Pseudomonas aeruginosa, Staphylococcus aureus, Haemophilus 
influenzae, Burkholderia cepacia, Achromobacter xylosoxidans, and Prevotella intermedia(1). 
The most concerning of these is also the most common: Pseudomonas aeruginosa. In adults, P. 
aeruginosa will colonize various portions of the conducting and respiratory zones of the 
respiratory tract, and if not treated can lead to the chronic infection state described above(1). The 
presence of multi-antibiotic resistant P. aeruginosa is a marker of advanced disease requiring 
extensive antibiotic therapy(1). However, treatment for this bacteria exists in the form of 
aggressive mixes of intravenous, oral, and inhaled antibiotics(1). If caught and treated early 
enough, the infection can be kept from developing into a serious, life-threatening state. 
Current research involves attempts to identify more effective treatments for the advanced 
stages of chronic bacterial infections. These studies have shown that the presence of biofilms 
increases the complexity of treating such infections. Biofilms are a community of microbial 
organisms (either one or multiple species of bacteria) that inhabit a favorable growing 
environment such as an extracellular mucus (in the case of biofilms for cystic fibrosis patients) 
but also including nonorganic environments such as rocks(3).  The exact mechanism that 
facilitates biofilm creation and adhesion is not well understood for most species(5). However, it is 
understood that the physical structure of the biofilm (which often exists as an extracellular matrix 
4 
 
or slime layer secreted by the organisms) creates an environment that is both ideal for bacterial 
growth and adaptation while simultaneously severely hindering the effectiveness of antibiotic 
treatment(3). As an exacerbating factor, these biofilms have been shown to be ideal habitats 
promoting colonization by multiple species of bacteria, including many of those listed above(1).  
Participation in biofilm communities by S. maltophilia is particularly problematic. Likely 
thanks to its origin in soil and aquatic ecosystems, S. maltophilia contains a diverse set of 
adaptations suited to hostile environments. These adaptations include an intrinsic high level of 
resistance to multiple antibiotics, the ability to utilize horizontal gene transfer, and a suite of 
efflux pumps that constitutively pump out harmful chemicals(11). Although S. maltophilia is not 
extraordinarily virulent, the frequency of isolation of S. maltophilia from chronically ill patients 
and compromised patients (including CF patients) is on the rise thanks in part due to improved 
detection methods(2) and more effective antibiotic treatment. Consequently, its natural resistance 
has become a concern. S. maltophilia could potentially act as a reservoir for resistance that could 
be passed on to more pathogenic organisms, such as P. aeruginosa(11).  
As the role of S. maltophilia in chronic infections emerges, the rates of its coinfections 
with P. aeruginosa and their possible synergism becomes an important topic of study. A study 
on biofilm formation between P. aeruginosa and S. maltophilia on in vitro IB3-1 cells (lung 
epithelial tissue) showed that, once a biofilm is created by P. aeruginosa, S. maltophilia is more 
readily able to adhere and colonize that biofilm(4). A biofilm containing multiple species is of 
concern, as it imposes greater challenges to conventional treatments(7), although again the exact 
etiology of this challenge has not been well understood. Furthermore, for CF patients in 
particular there is concern about coinfections, as the presence of S. maltophilia has been shown 
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to disrupt ion concentrations, which would further exacerbate the chemiosmotic problems 
resulting from the faulty CFTR(6).  
Although the specific nature of the effectors resulting in synergism between bacteria that 
makes the multi-species biofilms so robust are not fully understood, intercellular signaling is 
expected to be involved(5,7). Quorum sensing could play a role, as it is known to play an 
important role in the virulence of P. aeruginosa(14)  P. aeruginosa uses three different types of 
signaling systems (for quorum sensing) to communicate with itself as well as other species. The 
first two use acylated homoserine lactones (AHLs) that use two different receptor proteins: Las 
and Rhl(16). A third signaling system uses molecules belonging to the 2-alkyl-4-quinolone family 
(often referred to as PQS, or Pseudomonas quinolone signal) and is known to bind a response 
effector (pqsE)(15,16). Additionally, various strains of P. aeruginosa have been shown to secrete a 
suite of other compounds that may have signaling capabilities including pyocyanins, which, 
while they have inhibitory effects at high concentrations, have been shown to modulate gene 
regulation in lower concentrations(16).  As a result, this species is able to sense and respond 
appropriately to its own cell density as well as the composition of other species in its 
environment. Since S. maltophilia is a member of the γ-proteobacteria like P. aeruginosa and is 
likely responding to signals produced by P. aeruginosa, it is highly probable that it uses 
receptors similar to those produced by P. aeruginosa. Additionally, S. maltophilia is capable of 
horizontal gene transfer, which could possibly play a role in increasing the resistance of adjacent 
species(7). Ultimately, there must be a mechanism behind the synergistic behavior of these 






Initial computer genome mapping of S. maltophilia’s genome of the K279a strain has 
identified two genes, rpfG and Smlt_0278, as encoding quorum sensing proteins(11). Further 
bioinformatics analysis identified Smlt_0184, Smlt_1432, Smlt_1839, and Smlt_3567 as 
additional strong candidates to encode other quorum sensing proteins through their high 
similarity to known receptors. The purpose of this study was to determine, through insertional 
interruption (using the plasmid vector pEX18Tc), if these genes have any significant effect on 




















 Primers binding to internal sites in each of the six genes were purchased from Integrated 
DNA Technologies (Coralville, Iowa).  These primers were designed to amplify an internal ~500 
bp fragment of each gene.  This fragment, when cloned into pEX18Tc (which is not expected to 
be able to replicate in K279a(13)) would result in interruption of the desired gene due to single 
crossover of the plasmid into the genome. This would occur because the internal fragment 
Figure 1: Summary of amplification, ligation, and insertion events. 
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contains neither the start nor the stop of the gene, so neither gene fragment resulting from the 
recombination would result in a functional protein (Figure 1).  
The primers were based upon the genome sequence of the S. maltophilia strain K279a, in 
which the transmembrane receptors were identified(11). A summary of the genes, including the 
expected size of the product and the sequence of the primers, is provided in Table 1. 
Table 1: Summary of the genes and the primers used to amplify them.  
Gene Expected Product 
Size (bp) 





5′–GCG GGA TCC CCT GGT 
GCG AGG CGC ACC C–3′ 
5′–GCG GAA TTC CGC 






5′–GCG GGA TCC TAA GGC 
GGC GAC GCC GAC GGC–3′ 
5′–GCG GAA TTC TTA 






5′–GCG GGA TCC TAA GGA 
AGA CTC GCG CGCC GCT–3
′ 
5′–GCG GAA TTC TTA 






5′ – GCG GGA TCC CCA 
TCG CGG CAC GGT AGG G – 
3′ 
5′- GCG GAA TTC CGC 






5′ – GCG GGA TCC GTT 
CTC CAC CGT GCG CGT GG – 
3′ 
5′- GCG GAA TTC GGT 






5’ GCG GGA TCC TAA GCG 
GCA GAC TGC GGT GAT GG 
– 3′ 
5′ - GCG GAA TTC TTA 
GCC GAT CGC GGC CTG 
CAC G -3′ 
 Multiple PCR conditions were tested in order to determine those resulting in the best 
amplification of the desired products. To this effect, the polymerases Phusion (New England 
Biolabs(NEB), Ipswich, MA), HotStar (Qiagen, Hilden, Germany), and GoTaq green (Promega, 
Madison, Wisconsin) were used.  Gel electrophoresis was performed after each trial. A 2 log 
DNA ladder (NEB) was used as size comparison in order to determine if desired gene products 


















 PCR mixes with GoTaq green were made with 5 µl of GoTaq Green mix, 1 µl each of the 
desired product’s 20 pM forward and reverse primer, 1 μl approximately 200 ng/µl 
phenol/chloroform-purified K279a genomic DNA that had been previously obtained by other 
researchers, and 2 µl of water to bring the entire solution to 10 µl.  
HotStar 
 Each PCR mix prepared with HotStar as a polymerase were comprised of 1 µl of HotStar 
polymerase, 10 µl of HotStar 5× Buffer, and 10 µl of Q buffer. To this, 1 µl each of the 20 pM 
forward and reverse primer of desired amplification product was added. 1 µl of ~200 ng/μl 
K279a genomic DNA was added and 24 µl of water to bring the entire solution to 50 µL. 
Phusion 
 Phusion PCR mixes were comprised of 0.5 µl of Phusion, 10 µl of Phusion 5× buffer Hi 
GC, and 10 µl (10 mM) dNTPs. To this, 1 µl each of the 20 pM forward and reverse primer of 
desired amplification product was added. 1 µl of ~200 ng/μl phenol/chloroform-purified K279a 
Table 2: Basic PCR cycling used for the majority of PCR reactions. 
Step # Temp (Degrees Celsius) Time (min:sec) 
1 95 5:00 
2 95 0:30 
3 55 1:00 
4 72 2:00 
5 Go to step two 35 times. 
6 72 10:00 
7 4 hold 
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genomic DNA was added and 35.5 µl of water to bring the entire solution to 50 µl. The 
extension temperature (step 4, table 2) was adjusted to 68°C for Phusion. 
Gel Electrophoresis 
 To determine whether PCR products contained products of the appropriate size, the 
products were examined by electrophoresis on 1% agarose gels that had been stained with 
ethidium bromide.  Gels were loaded with 5 µl of the desired PCR mix (with loading dye added 
as necessary) or 2-log DNA ladder and then run at constant 100 volts. Duration varied between 
30-60 minutes, depending on the size of the gel.  The image of each gel was obtained after 
exposure to ultraviolet light in a VersaDoc Model 4000 (Bio-Rad, Hercules, CA). PCR products 
were compared to the 2 Log DNA ladder for size determination. 
Modifications to basic PCR procedure 
In many cases, extra bands indicating nonspecific amplification were observed. To rectify 
this, the desired bands were gel purified using the QIAquick Gel Extraction Kit (Qiagen, Hilden, 
Germany), and this purification product was used in a second round of amplification using 
HotStar polymerase as described above. This methodology was only performed with HotStar 
polymerase, since GoTaq green was only used for screening (the products never needed to be 
isolated) and Phusion was ineffective for specific amplification of the desired products. 
Gel extraction followed the manufacturer protocol, and began with excision of the DNA 
fragment from the gel with a scalpel. The gel slice was weighed, and 3 volumes of Buffer QG 
was added for 1 volume gel (100 mg gel was estimated to be roughly equivalent to 100 µl as per 
kit instructions). This was incubated at 50°C for 10 minutes or until the gel dissolved completely. 
To this 1 gel volume of isopropanol was added. This mixture was placed in the QIAquick Spin 
Columns and centrifuged at 14,000 rpm in a tabletop centrifuge for 1 minute. The flowthrough 
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was discarded. 500 µl of Buffer QG was added to this column and centrifuged again for 1 minute 
at 14,000 rpm. The flowthrough was discarded again. 750 µl of Buffer PE was added, and 
centrifugation was repeated.  Again, flow through was discarded. The column was then 
transferred to a new microcentrifuge tube. To elute the DNA, 50 µl of ddH2O was added and 
centrifugation was repeated. The resulting mixture could be used again in subsequent PCR 
reactions to amplify desired products. 
Purification of pEX18Tc 
 The vector into which the PCR-amplified gene products were to be inserted for 
interrupting the genes in S. maltophilia, pEX18Tc, is able to replicate in E. coli but not S. 
maltophilia and provides tetracycline resistance(13).  In order to have sufficient quantities of 
pEX18Tc for cloning, it was first purified from DH5α E. coli using the Qiagen Spin Miniprep kit 
using the manufacturer’s protocol (Qiagen, Hilden, Germany). The purified pEX18Tc was 
quantified on a Nanodrop 2000 (Nanodrop, Wilmington, Delaware) by measuring absorbance at 
260 nm. 
 
Figure 2: Structure of the plasmid pEX18Tc used as a vector (13). 
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Purifications and Restriction Enzyme Digestion 
  Once amplification of the desired PCR products had been confirmed with gel 
electrophoresis, the DNA products and plasmid into which they were going to be inserted were 
digested using restriction enzymes BamHI and EcoRI (NEB), both of which have unique 
restriction sites in the multicloning locus that interrupts lacZα in pEX18Tc (Figure 2).  Prior to 
digestion, the amplification products were purified from the PCR mixes. This was done using 
QIAquick PCR Purification Kit (Qiagen, Hilden, Germany) according to manufacturer 
instructions. 
The resulting mixture was analyzed on a Nanodrop 2000 (using ddH2O as a blank) to 
determine the concentration of purified gene products so that 1 μg of each of the amplification 
products and 6 μg of pEX18Tc could be digested in the mixtures outlined in Table 3. 
 
This mixture was incubated at 37°C for 1 hour. Afterwards, an additional 1 µl of BamHI 
and EcoRI was added to digests 1-6. For digest 7, 3 µl of BamHI and EcoRI each were added as 
Table 3: Summary of prepared mixtures for restriction enzyme digest.  


















2  µl 
 
2  µl 
 
2  µl 
 
2  µl 
 
2  µl 
 
2  µl 
 
4  µl 
BamHI 
 
1  µl 1  µl 1  µl 1  µl 1  µl 1  µl 6  µl 
EcoRI 
 
1  µl 1  µl 1  µl 1  µl 1  µl 1  µl 6  µl 
CIP 
 




6.3 µl 6.5  µl 9.0  µl 9.9  µl 8.7  µl 7.4  µl 18.3 µl 
ddH2O 
 
9.7  µl 9.5  µl 7.0 µl 6.1  µl 7.3  µl 8.6  µl 4.7  µl 
Total 
volume 
20  µl 20  µl 20  µl 20  µl 20  µl 20  µl 40  µl 
DNA to be digested was determined with absorbance at 260 nm with a Nanodrop (Thermo Fisher). Water 
was added to each solution to bring to total solution to a total volume of 20 µl for digests 1-6, and 40 µL 
for digest 7. CIP (calf intestinal phosphatase) was used only in digest 7 to prevent religation. 
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well as 1 µl of CIP (a phosphatase which dephosphorylates DNA ends to prevent the plasmid 
that is cut with a single restriction enzyme from ligating with itself). This mixture was allowed to 
incubate for an additional hour at 37°C. The digests were then purified with Qiagen Spin 
Miniprep kit (Qiagen) following the manufacturer’s protocol.  
Ligation of inserts Into Vector 
 The previously prepared mixtures were then subjected to ligation. Six tubes were 
prepared with 250 ng purified, digested pEX18Tc to which the appropriate digested insert was 
added at a five-fold molar excess. To this mixture, 3 µl of 10× DNA ligase buffer and 1 µl of T4 
DNA ligase was added. Sterile ddH2O was added to bring the final volume of the ligation 
mixture to 30 µl. As controls, mixtures were prepared using only cut pEX18Tc and ligase, 
omitting the insert, and cut vector alone, both of which were supplemented with the required 
water to bring the mixtures to 30 µl. All mixtures were incubated overnight at 16°C. 
Preparation of competent E. coli DH5α cells 
 In order to transform the ligations into cells so that the resultant plasmids could be 
replicated and stored, competent E. coli cells were prepared using the following steps: 
 400 µl of an overnight culture of E. coli strain DH5α was grown in lysogeny broth (LB). 
This culture was incubated at 37°C on a roller drum for 1.5 hours to ensure exponential phase 
growth.  
 After 1.5 hours, the tubes of inoculated broth were put on ice for 15 minutes. They were 
then centrifuged at 14,000 rpm for two minutes at 4°C. The supernatant was discarded, and the 
pellet was resuspended using 500 µl of ice cold 100 mM MgCl2. This mixture was centrifuged at 
14,000 rpm for two additional minutes at 4°C. The supernatant was discarded, and the pellets 
were resuspended in 500 µl of 100 mM of CaCl2. This mixture was left on ice for 30 minutes 
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before the cells were repelleted. The supernatant was discarded. The cells were resuspended in a 
mixture of 100 µl 15% glycerol and 100 mM CaCl2 solution. This mixture was stored at -80°C 
until needed for transformations. 
Transformation of ligations into chemically competent E. coli 
Chemically competent DH5α cells were thawed on ice. 100 µL of these cells was added 
to each of 8 tubes containing the eight previously prepared ligation mixes and were vortexed on 
high for 2-3 seconds. As a positive control, an additional transformation was made using only 
undigested pEX18Tc plasmid. As a negative control, a transformation mixture was made without 
a DNA template.  These mixtures were incubated on ice for 10 minutes, then at 42°C for 1 
minute, and back on ice for an additional 10 minutes. 1 ml of sterile LB was added to each 
transformation, and the cells were then incubated at 37°C and approximately 300 rpm for 1 hour 
to promote expression of the resistance markers on the plasmids. 100 µl of this solution was 
plated on LB plates with Tet(10) (tetracycline, 10 μg/ml) and spread using glass beads. These 10 
agar plates were incubated overnight at 37°C. Growth was assessed by examining number and 
size of colonies that formed. 
 The transformed colonies were transferred onto fresh LB Tet(10) plates using sterile 
toothpicks and allowed again to grow overnight. In the morning, select colonies (5 from each 
ligation) were selected for use as templates in colony PCR reactions using the GoTaq green 
procedure outlined above, substituting the template with select colonies. This was done in order 
to identify colonies containing insert of the appropriate size. Positive controls were made using 




 The results of the PCR were used to identify colonies that contain the transformed 
plasmid with the correct insert. Promising colonies were subject to plasmid purification (as 
outlined above, for isolating pEX18Tc originally) to eventually be used in sequencing to confirm 
that transformation occurred. Additionally, the same colonies were then prepared to conjugate 
the plasmid from E. coli into S. maltophilia because identical sequence across the entire insert 
was not deemed to be essential for single crossover insertional disruption of the desired genes 
(Figure 1). 
Conjugation from E. coli into S. maltophilia 
 In order to transfer the plasmid from E. coli into S. maltophilia¸ the helper strain E. coli 
pRK2013 which allows interspecies conjugation(12) was used. E. coli DH5α containing the 
appropriate plasmids were used to inoculate 5 mL of LB Tet(10). S. maltophilia K279a was 
placed in 5 ml of LB broth containing no antibiotic. The helper strain of E. coli (pRK2013) was 
placed in 5 ml of LB broth with kanamycin (50 μg/ml). These were incubated at 37°C and 
approximately 300 rpm overnight.  
 Following overnight incubation, S. maltophilia K279a was heat shocked at 42°C for two 
hours. 400 µl of heat-shocked K279a was mixed with 200 µl of donor E. coli (containing the 
desired pEX18Tc derivative) and 200 µl of helper E. coli pRK2013. This mixture was spun at 
1500 rpm for 1 minute. The supernatant was discarded and the cells were resuspended in 100 µl 
of plain LB broth. This mixture was place on the mating plates (LB without antibiotics) and 
incubated overnight at 37°C. 
 On the following day, the overnight mating growth was resuspended in 1 ml of drug-free 
LB broth. 300 µl and 100 µl of this suspension were plated on agar plates containing Tet 20 and 
irgasan 25 µg/ml. Tetracycline selects for bacteria containing pEX18Tc. Irgasan prevents E. coli 
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growth but not S. maltophilia growth. Due to an increased generation time because of the high 
concentrations of antibiotics used and the lower temperature, these plates were incubated for 3 
days. Background growth was detected, and so suspected S. maltophilia colonies were isolated 
using sterile toothpicks and struck for isolation on fresh plates with Tet 20 and irgasan 25.  
 Isolated transconjugants were expected to contain an interruption of the target gene. This 
interruption would occur as a result of the single cross-over event that would occur between the 
inserted sequence in pEX18Tc and the original insertion sequence on K279a’s genome. 
Interruption would cause any products produced from transcription of the gene to be 
nonfunctional, as both ends of the gene are incomplete (Figure 1). 
 To screen for the desired transconjugants, isolated colonies were subject to PCR using 
GoTaq green procedure outlined above, with an increase in the elongation time (step 4, table 2) 
to 10 minutes for each cycle. A second PCR was performed with HotStar (with the same increase 
in the elongation time) because GoTaq Green has limited processivity.  For these PCR reactions, 
the template was colony matter from the isolated S. maltophilia transconjugant colonies. As a 
positive control K279a genomic DNA was used as template. 
 A PCR was also performed using the GoTaq green procedure and primers for the 
sequences on pEX18Tc immediately upstream and downstream of the multicloning locus.  A 
product from this PCR would indicate that there was intact plasmid in the S. maltophilia cells (no 
insertion into the desired sequence). The normal PCR temperature cycling was used (Table 2), 
and the gel was run with normal conditions. 
Growth of S. maltophilia with P. aeruginosa. 
C3719, a cystic fibrosis clinical isolate of P. aeruginosa for which the genome sequence 
is known, was used to assay the growth with the conjugated S. maltophilia colonies. C3719 was 
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prepared from freezer stock and struck for isolation. The colonies of both C3719 and each of the 
transconjugants were inoculated into LB broth and grown overnight at 37°C. The following 
morning, 1 μl of the inoculated broth was spotted on LB agar plates without antibiotics. Colonies 
to be tested for effects on growth were placed 1cm apart and each pairing was assayed in 
triplicate. For each of the conjugations, several controls were prepared. One control involved 
growing two C3719 colonies together, another with C3719 next to wild-type K279a, and finally 






















 PCR followed by gel electrophoresis was used to identify the conditions leading to 
optimal amplification of the desired products. Initially, GoTaq green was used to verify that the 
primers could be used to amplify the desired gene products (Figure 3). 
Due to GoTaq green’s low fidelity, it was not used for to amplify products for ligation. 
Both HotStar and Phusion are described by their manufacturers as having higher fidelity than 
GoTaq Green, although their amplification product yield can sometimes be less robust than 
GoTaq Green. 
Figure 3: Initial GoTaq Green PCR. L = 2 Log DNA ladder. PCR1: 
Smlt_1839, 2: Smlt_3567, 3: Smlt_0278, 4: Smlt_1432, 5: rpfG, 6:   
Smlt_0184. Desired amplification events appear successful with the 
given primers and GoTaq Green. 
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Initially, HotStar was only able to successfully amplify Smlt_0184, Smlt_1432, and 








Figure 4: HotStar PCR. L = 2 Log DNA ladder. PCR1: rpfG, 2: Smlt_0184,  
3: Smlt_0278, 4: Smlt_1432, 5: Smlt_1839, 6: Smlt_3567. Figure shows  
successful amplification of Smlt_0184, Smlt_1432, and Smlt_1839 with  




Amplification of Smlt_0278 and Smlt_3567 was then attempted with Phusion, but only 









Figure 5: Phusion PCR. L = 2 Log DNA ladder. PCR1: Smlt_0278.  





Due to the ineffectiveness of Phusion, the amplification of rpfG, Smlt_0278, and 
Smlt_3567 was repeated with HotStar, using purified PCR products from previous attempts that 
showed promising results. These reactions resulted in strong bands of rpfG products in both 
attempts. While reactions with Smlt_0278 and Smlt_3567 produced bands of the desired size, 
they also produced a significant amount of additional bands of undesired products (Figure 6). 
 
Figure 6: Repeat HotStar PCR using previous PCR mixes as templates. L = 2 log 
ladder. Reaction 1 corresponds to rpfG. Reaction 2 corresponds to Smlt_0278.  




Using gel purified products of appropriately sized bands of PCR amplification of 
Smlt_0278 and Smlt_3567, PCR was repeated with HotStar resulting in successful amplification 
(Figure 7). 
Purifications, Restriction Enzyme Digestion and Ligations 
Once all 6 gene inserts had been amplified, they could be digested in preparation for 
ligation into the vector. After digestion, the digests were purified and the concentrations of the 
resultant products were determined to determine the proper volume to achieve 5 fold-molar 
Figure 7: Repeat HotStar PCR using previous PCR mixes as 
templates. L = 2 log ladder. Reaction 1 corresponds to rpfG. 
Reaction 2 corresponds to Smlt_0278. Reaction 3  
corresponds to Smlt_3567. 
23 
 
excess of the amplified insert with pEX18 for digestion. Ligations were then performed and 






        
 
Transformation of ligations into chemically competent E. coli 
The ligations were then transformed into chemically competent DH5α cells. 
Transformants were plated on LB with tetracycline and incubated. Assessment of the growth is 
show in Table 5. 
Table 5: Colony densities from plated E. coli on Tet(10) plates post transformation. 
Transformation DNA CFUs/mL 
1 rpfG 220 
2 Smlt_0184 1110 
3 Smlt_0278 910 
4 Smlt_1432 2160 
5 Smlt_1839 4920 
6 Smlt_3567 2560 
7 No insert 80 
8 No ligase, no insert 0 
9 Positive control: pEX18Tc Too many to count 
10 No template 0 
Results show that transformation proceeded as expected, as the negative controls (8 and 10) did 
not show any growth and the remainder did grow as was expected. 
Table 4: Concentrations of purified digest products 
Digest Concentration (ng/nL) 
1 – rpfG 18.9 
2 – Smlt_0184 30.2 
3 – Smlt_0278 28 
4 – Smlt_1432 35.9 
5 – Smlt_1839 37.9 
6 – Smlt_3657 29 
7 – pEX18Tc 15.6 
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These colonies were transferred onto fresh LB plates and allowed to grow overnight. Five 
colonies from each ligation examined by colony PCR to identify colonies with insert of the 
desired size (Figure 8). 
 
 
Figure 8: cPCR (colony PCR) of five colonies from each of the 6 transformations.  
Reactions 11-17 represent colonies transformed with rpfG. 21-27: Smlt_0184.  
31-37: Smlt_0278. 41-47: Smlt_1432. 51-57 Smlt_1839. 61-67: Smlt_3567. 11-15,  
21-25, 31-35, 41-45, 51-55, and 61-65 represent the 5 colony isolates used as  
templates.  Reactions 16, 26, 36, 46, 56, and 66 represent positive controls for each 
reaction where the template was 1 µl of K279a DNA. Reactions 17, 27, 37, 47, 57,  
and 67 were negative controls, where 1 µl ddH2O was used as a template. The  




Figure 9: Repeat cPCR (colony PCR) of five colonies from 4 of the transformations. 
Reactions 31-37 represent Smlt_0278. 41-47: Smlt_1432. 51-57 Smlt_1839. 61-67: 
Smlt_3567. 31-35, 41-45, 51-55, and 61-65 represent the 5 colony isolates 
used as templates.  Reactions 36, 46, 56, and 66 represent positive controls for each 
reaction where the template was 1 µl of K279a DNA. Reactions 37, 47, 57, and 67  
were negative controls, where 1 µl ddH2O was used as a template. The negative  
controls show bands corresponding to the primers that were added. 
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Because PCR on colonies from transformations 3-6 failed to identify colonies producing 
a single band of the desired size, the PCRs were repeated using different colonies (Figure 
9).These PCR reactions (Figure 8 and 9) identified for two rpfG, two Smlt_0184, four 
Smlt_0278, three Smlt_1432, two Smlt_1839, and two Smlt_3657 colonies that produced bands 
that appeared to be the appropriate size. Plasmids from these colonies were then purified and 
used as templates in subsequent PCR reactions (Figure 10).  
 
 
These results identified the best candidates to be used for conjugation into S. maltophilia 
(11, 21, 22, 41, 42, 51, 52, 61, and 62). There were no reactions for Smlt_0278 that produced 
Figure 10: cPCR post plasmid purification. Reactions 11-14 represent rpfG. 21, 22,  
26, 27: Smlt_0184. 31-34: Smlt_0278. 41-45: Smlt_1432. 51-54: Smlt_1839. 61- 
64: Smlt_3657. 13, 26, 33, 44, 53, and 63 represent positive controls (pEX18Tc  
used as a template). 14, 27, 34, 45, 54, and 64 represent negative controls,  
where ddH2O was used as a template. The negative controls show bands  
corresponding to the primers that were added. 
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results sufficient to proceed with conjugation (additional bands, bands in the negative control), 
so that reaction was left out for the remainder of experimentation. 
Conjugation from E. coli into S. maltophilia 
The previously identified nine colonies were used for conjugation. All of the 
conjugations into S. maltophilia had at least 30 colonies after 2 days incubation at room 
temperature.  After 3 days there was background growth on all of the plates, so larger colonies 
were transferred onto fresh LB Tet (20) Irg (25) plates using sterile toothpicks and grown 
Figure 11: cPCR of isolate S. maltophilia colonies after conjugation. L corresponds to  
two log ladder used for size identification. Reaction 11-14 are four colonies for the  
first conjugation rpfG. 21-24: conjugation 2, 31-34 conjugation 3, both corresponding  
to Smlt_0184. 41-44: conjugation 4, 51-54: conjugation 5, both corresponding to 
Smlt_1432. 61-64: conjugation 6, 71-74: conjugation 7, both corresponding to  
Smlt_1839. 81-84: conjugation 8, 91-94: conjugation 9, both corresponding to  
Smlt_3657. 15, 35, 55, 75, and 95 correspond to positive controls in which wild-type 
K279a was added in place of transconjugant colonies. 16, 36, 56, 76, and 96  




overnight at 37°C. These were then streaked for isolation and used in another PCR to assay for 
desired products (Figure 11). 
 The products after conjugation were expected to include bands of the original insert size 
as well as bands approximately 6 kb larger than the original genes because they should include 
the entire plasmid integrated into the gene (Figure 1). Findings depicted in Figure 11 suggest that 
conjugation may not have occurred in the desired location, but this is not entirely conclusive 
because GoTaq Green often is not processive enough to amplify more than 2000 bp.  
The PCR was repeated with only 2 colonies representing each gene to be interrupted with 
primers for pEX18Tc (Figure 12). These PCR reactions should show a product only when the 
plasmid is present without recombination at the gene of interest.  If the cloned insert is intact the 
PCR will give a product that is the size of the insert as the primers will amplify across the insert.  
Figure 12: Repeat cPCR of transconjugant colonies using pEX18Tc primers. L = log  
2 ladder for size comparison. Conjugation 1(rpfG) was plated in lanes 1a and 1b,  
with two different isolated colonies. Lane 2 and 3 are colonies from conjugations 2  
and 3 (Smlt_0184). 4/5: Conjugations 4 and 5 (Smlt_1432). 6/7: Conjugations 6  
and 7 (Smlt_1839). 8/9: Conjugations 8 and 9 (Smlt_3657). 
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If the insert has recombined into the chromosome through single crossover, the primers will be 
pointing out and would lead to amplification of the entire genome except the plasmid sequence 
to produce a band, and this is extremely unlikely to happen in the extension time allotted. The 9 
transconjugant colonies were renamed (Table 6). K279aΔrpfG#1, K279aΔsmlt0184#2, 
K279aΔsmlt1432#2, K279aΔsmlt1839#1, and K279aΔsmlt3657#2 lacked bands the size of the 







Growth of S. maltophilia with P. aeruginosa 
Co-growth of P. aeruginosa and one isolate of each knockout strain was assayed. 
Transconjugants were chosen and individually plated 1 cm away from P. aeruginosa C3719 in 
triplicate. The plates were incubated overnight at 37°C. Growth was examined for qualitative 






Table 6: New naming scheme for transconjugant colonies. 
Insert Conjugation Original isolate colony # New name 
rpfG 1 11 K279aΔrpfG#1 
rpfG 1 12 K279aΔrpfG#2 
Smlt_0184 2 21 K279aΔsmlt0184#1 
Smlt_0184 3 41 K279aΔsmlt0184#2 
Smlt_1432 4 1 K279aΔsmlt1432#1 
Smlt_1432 5 21 K279aΔsmlt1432#2 
Smlt_1839 6 41 K279aΔsmlt1839#1 
Smlt_1839 7 1 K279aΔsmlt1839#2 
Smlt_3657 8 23 K279aΔsmlt3657#1 





















































































































































































































































































































 Out of the three polymerases examined for amplification of the desired gene products 
(GoTaq Green, HotStar, and Phusion), HotStar appeared to be the best choice due to the balance 
of product yield and polymerase fidelity. It produced consistent results, although it occasionally 
required gel purification to isolate the desired amplification products. 
 GoTaq green was a useful polymerase, as it was an efficient means of running PCRs 
(low cost, less complicated mix) and it consistently showed bands of the desired size. For 
amplifications resulting in products to be used for cloning it was not used due to its low fidelity. 
However, it was used extensively to determine whether constructs had the appropriate size. 
Transformation of Ligations into Chemically Competent E. coli 
 E. coli DH5α was chosen as the initial species for transformation as it provided an easy, 
efficient way to replicate the intact plasmid. The transformed colonies that were produced were 
easy to handle; they could be frozen (for long term storage) and readily grew on simple LB agar 
plates and in liquid broths as needed. A large stock was easily produced and then used for 
conjugation. 
The results of the PCRs for transformed colonies of E. coli (Figure 8, Figure 9, and 
Figure 10) only occasionally showed evidence of successful transformation of the ligated 
plasmid. In many cases, there were additional unexpected products. Explanations for this 
phenomenon include insertion of multiple copies of the cloned sequence into the plasmid in 
tandem or nonspecific binding of the primers to E. coli genomic DNA. As a result of the 
additional bands, several attempts were required to find colonies that contained the desired 
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inserts. Successful insertion of Smlt_0278 was not identified after multiple screening attempts, so 
this gene was not included in conjugations and growth assays 
Conjugation and Growth testing 
 Cloning produced plasmids in E. coli that appear to have the desired sequence for five of 
the desired genes. These plasmids were conjugated into S. maltophilia K279a resulting in 
transconjugants with the desired antibiotic resistances from each plasmid. However, there 
appeared to be conflicting evidence as to whether or not the conjugation and recombination 
occurred as intended. pEX18Tc lacks a S. maltophilia origin of replication and is therefore 
unable to replicate(13). Additionally, without the tetracycline resistance gene from pEX18Tc 
plasmid, the K279a strain of S. maltophilia cannot grow on tetracycline present on the selective 
plates. E. coli cannot grow in the presence of irgasan. This means that only S. maltophilia that 
has acquired tetracycline resistance (most likely from the plasmid) and incorporated the 
associated genes into its chromosome can grow on the irgasan and Tetracycline. Furthermore, 
the colonies appeared in coloration more like S. maltophilia than E. coli leading to the 
assumption that they are not E. coli colonies that acquired irgasan resistance from S. maltophilia.  
 The growth of S. maltophilia colonies on the irgasan and Tetracycline plates is evidence 
that the transformation and recombination was successful. However, two rounds of PCR (with 
GoTaq Green and HotStar) did not show strong evidence of recombination events. Due to the 
interruption of the gene, the PCR should result in bands of two different sizes: one the size of the 
gene and the other 6.2 kB larger (Figure 1). Instead, the products of amplification, for the most 
part, were the same size as the original gene. 
 One explanation for this event could be that the recombination did not result in the gene 
being interrupted. This could occur if there was another region on pEX18Tc that contained a 
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similarity the K279a genome for which recombination could occur. In this case, the plasmid 
would recombine and confer tetracycline resistance to the bacteria without knocking out the 
gene, and the resulting PCR would only amplify the original gene. 
 It is possible that all the colonies we isolated were spontaneous tetracycline mutants, but 
the probability of that happening is quite small (and the negative controls did not show any 
growth). It is also possible that unlike our expectations pEX18Tc is able to replicate in S. 
maltophilia.  The actual requirements for replication in S. maltophilia are unknown, but 
pEX18Tc is only known to contain an origin of replication for E. coli, and S. maltophilia is much 
more closely evolutionarily related to P. aeruginosa, where pEX18Tc cannot replicate, than it is 
to E. coli.  Recent unpublished work in the lab of Dr. Deborah Yoder-Himes suggests that 
pEX18Tc is unable to replicate in K279a. The most likely explanation, however, is that the 
smaller PCR product is preferentially made as large products can be used as templates for small 
products in subsequent cycles but small products cannot be templates to amplify the large 
product (Figure 1). As such, this PCR was an inconclusive test of the structure of the 
transconjugants. 
 Even if the conjugation and recombination resulted in the desired construct and the gene 
was interrupted, significant difference in the growth of S. maltophilia in the presence of P. 
aeruginosa was not observed in any of the trials. Direct side-by-side growth showed no 
difference from the control (Figure 13). This finding suggests that the insertional interruption had 
no effects on growth in this in vitro setting. However, this may or may not relate to how these 
transconjugants would behave in vivo settings. Significant signaling may occur when the two 
bacteria grow together, or only in models that place the two species in similar environments as 
found in the human respiratory tract. Further study could be done to determine if any of these 
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transconjugants have significant effect on growth in models that promote biofilm formation and 
settings that mimic the environment found in cystic fibrosis patients. Additionally, it is possible 
that 1 cm is too far apart for effectors released by one of these species to impact growth of the 
other species. Bacteria are in much closer proximity in biofilm habitats. 
 In conclusion, it is uncertain at this time if insertional interruption was successful. 
However, the E. coli transformants have shown that they have successfully taken up plasmids 
with the desired inserts. The purified plasmids from these are awaiting sequencing at this time. 
Experiments proceeded without sequencing of the inserts because, since they would be used to 
interrupt the respective gene, 100% identity, while useful, was not deemed to be essential.  
Assuming sequencing confirms the correct insertion, these colonies can still be used to reattempt 
insertion interruption with S. maltophilia and then subsequent growth testing with P. aeruginosa. 
Additionally, more models of growth that more accurately mimic the biofilm environment 
created between these two species in cystic fibrosis patients could be tested with both current 
existing and new transconjugant strains of S. maltophilia. Finally, it is possible that additional 
signaling receptors have yet to be identified that play the most significant role in the growth 
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